Waystar Holding Corp (WAY) stock soared 7.34% in pre-market trading on Thursday following the release of its strong first-quarter 2025 results and raised full-year guidance. The healthcare technology company reported better-than-expected earnings and revenue, demonstrating resilience in a challenging economic environment.
Waystar reported Q1 non-GAAP earnings of $0.32 per diluted share, up from $0.20 a year earlier and in line with analyst expectations. Revenue for the quarter ended March 31 came in at $256.4 million, up 14% year-over-year and surpassing the FactSet consensus estimate of $248.3 million. The company's performance was driven by robust patient payment utilization and strong subscription revenue growth of 18% year-over-year.
In response to the strong results, Waystar raised its full-year 2025 guidance. The company now expects non-GAAP EPS of $1.31 to $1.34 on revenue of $1.01 billion to $1.02 billion, up from its previous forecast in February. The raised outlook reflects confidence in Waystar's ability to capitalize on the growing demand for its AI-powered healthcare payment solutions. Following the earnings release, several analysts adjusted their price targets, with BofA Global Research raising its price objective to $49 from $48, signaling continued optimism about the company's prospects.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.